A detailed history of Woodline Partners LP transactions in Zentalis Pharmaceuticals, Inc. stock. As of the latest transaction made, Woodline Partners LP holds 1,055,282 shares of ZNTL stock, worth $3.4 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
1,055,282
Previous 1,517,077 30.44%
Holding current value
$3.4 Million
Previous $6.2 Million 37.59%
% of portfolio
0.04%
Previous 0.06%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$2.9 - $4.57 $1.34 Million - $2.11 Million
-461,795 Reduced 30.44%
1,055,282 $3.87 Million
Q2 2024

Aug 14, 2024

BUY
$4.09 - $16.13 $327,408 - $1.29 Million
80,051 Added 5.57%
1,517,077 $6.2 Million
Q1 2024

May 15, 2024

BUY
$10.83 - $16.49 $362,512 - $551,969
33,473 Added 2.38%
1,437,026 $22.6 Million
Q4 2023

Feb 14, 2024

BUY
$9.84 - $20.13 $3.97 Million - $8.12 Million
403,553 Added 40.36%
1,403,553 $21.3 Million
Q3 2023

Nov 14, 2023

SELL
$19.63 - $28.29 $1.86 Million - $2.69 Million
-94,974 Reduced 8.67%
1,000,000 $20.1 Million
Q2 2023

Aug 14, 2023

SELL
$17.41 - $30.05 $18.6 Million - $32.2 Million
-1,070,577 Reduced 49.44%
1,094,974 $30.9 Million
Q1 2023

May 15, 2023

BUY
$16.14 - $24.94 $32.6 Million - $50.4 Million
2,019,032 Added 1378.0%
2,165,551 $37.2 Million
Q4 2022

Feb 14, 2023

SELL
$18.07 - $25.6 $3.13 Million - $4.43 Million
-173,228 Reduced 54.18%
146,519 $2.95 Million
Q3 2022

Nov 14, 2022

BUY
$20.23 - $31.73 $2.8 Million - $4.39 Million
138,475 Added 76.39%
319,747 $6.93 Million
Q2 2022

Aug 15, 2022

BUY
$17.91 - $52.25 $2.52 Million - $7.34 Million
140,524 Added 344.86%
181,272 $5.09 Million
Q1 2022

May 16, 2022

SELL
$41.58 - $80.89 $13.6 Million - $26.5 Million
-327,425 Reduced 88.93%
40,748 $1.88 Million
Q4 2021

Feb 14, 2022

SELL
$66.92 - $84.79 $9.35 Million - $11.8 Million
-139,674 Reduced 27.5%
368,173 $30.9 Million
Q3 2021

Nov 15, 2021

BUY
$46.83 - $73.5 $101,714 - $159,642
2,172 Added 0.43%
507,847 $33.8 Million
Q2 2021

Aug 16, 2021

BUY
$37.41 - $62.25 $13.5 Million - $22.5 Million
361,514 Added 250.77%
505,675 $26.9 Million
Q1 2021

May 17, 2021

BUY
$35.69 - $52.72 $148,506 - $219,367
4,161 Added 2.97%
144,161 $6.26 Million
Q4 2020

Feb 16, 2021

BUY
$31.71 - $57.97 $67,098 - $122,664
2,116 Added 1.53%
140,000 $7.27 Million
Q3 2020

Nov 16, 2020

BUY
$27.03 - $47.97 $2.55 Million - $4.52 Million
94,158 Added 215.34%
137,884 $4.51 Million
Q2 2020

Aug 14, 2020

BUY
$23.2 - $54.8 $1.01 Million - $2.4 Million
43,726 New
43,726 $2.1 Million

Others Institutions Holding ZNTL

About Zentalis Pharmaceuticals, Inc.


  • Ticker ZNTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,983,600
  • Market Cap $183M
  • Description
  • Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...
More about ZNTL
Track This Portfolio

Track Woodline Partners LP Portfolio

Follow Woodline Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.